Product Transparency 40 years of research dedicated to bringing you premium, scientifically-validated formulations
In the HA-first sequence (Figure 3A), after 1 month of HA-only treatment (V1 to V3), cytokine concentrations remained largely at baseline, with the sole exception of IFN-, which showed a modest but significant increase (p = 0.028)
Each component is structurally characterized and combined in a standardized formulation for use in laboratory research environments
Mol Pharmacol 50: 656-661, 1996
Yes, several vendors sell a BPC-157 and TB-500 blend for research, and Koi, Limitless Life Nootropics, and Swiss Chems all list combination products